Hypercalcemia Clinical Trial
Official title:
Retrospective Analysis of Causes, Clinical Presentation and Treatment in Patients With Hypercalcaemia in the Emergency Department of a Tertiary German Hospital
Patients with hypercalcemia were identified in the patient population of a German emergency department during a 11 year time period and studied regarding reproducibility of elevated calcium values, causes of hypercalcemia, symptoms. acute renal injury, mortality and treatment response.
Patients, who presented to the emergency department of a tertiary German hospital with a total calcium of ≥2.65 mmol/l between January 2010 and March 2021, was retrospectively studied. From the electronic patient records we analyzed if the elevated calcium values were reproducible in follow-up measurements, identified the cause of hypercalcemia, listed the symptoms, investigated a correlation between calcium and creatinine values to study acute renal injury directly due to hypercalcemia, calculated the mortality rate stratified by the calcium value on presentation and studied the treatment response regarding lowering calcium values by different treatments. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT02711059 -
Insulin Resistance in Primary Hyperparathyroidism
|
N/A | |
| Recruiting |
NCT05585593 -
Registry for Hypoparathyroidism Wuerzburg
|
||
| Terminated |
NCT01725113 -
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
|
Phase 4 | |
| Completed |
NCT01460030 -
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
|
Phase 3 | |
| Completed |
NCT00325104 -
Cinacalcet to Treat Familial Primary Hyperparathyroidism
|
Phase 3 | |
| Recruiting |
NCT03935984 -
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
|
Phase 4 | |
| Withdrawn |
NCT01329666 -
Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
|
Phase 2/Phase 3 | |
| Completed |
NCT00891813 -
Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
|
Phase 4 | |
| Completed |
NCT00674154 -
Effect of Vitamin D Treatment in Primary Hyperparathyroidism
|
Phase 2/Phase 3 | |
| Completed |
NCT04299425 -
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
|
N/A | |
| Completed |
NCT00975221 -
Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
|
Phase 3 | |
| Withdrawn |
NCT03516747 -
Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland
|
N/A | |
| Completed |
NCT00485706 -
Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
|
N/A | |
| Recruiting |
NCT01647503 -
Differentially Expressed Proteins in Sporadic Parathyroid Tumors
|
N/A | |
| Completed |
NCT01042626 -
Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
|
N/A | |
| Not yet recruiting |
NCT01021280 -
Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome
|
N/A | |
| Not yet recruiting |
NCT01226810 -
The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to Exploration
|
N/A | |
| Terminated |
NCT00415584 -
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
|
Phase 1/Phase 2 | |
| Completed |
NCT00581828 -
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
|
Phase 4 | |
| Completed |
NCT00126386 -
Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
|
N/A |